You have searched for "2 Million Patient"

Showing 1-1 of 1

Sort by: Newest | Oldest | Relevance

Business 15 Sep 2014 | 9:02 AM

Costly eye drug and far cheaper alternative have similar side effects

LONDON: Injecting Roche's cancer drug Avastin as a cheap eye treatment does not appear to increase deaths or serious side effects, according to an independent study that is likely to fuel a row over the medicine's unapproved use.